Mitra Eftekhar Yazdi; Vahideh Moghaddam Hosseini; Nasrin Hashemian nejad
Volume 22, Issue 2 , May and June 2015, , Pages 444-449
Abstract
The incidence of molar pregnancy and a live fetus is extremely low; however, since it can lead to some sever complications in pregnancy, its correct diagnosis is really vital. Moreover, making decision about termination or continuation of pregnancy is yet controversial. This study presents a dizygotic ...
Read More
The incidence of molar pregnancy and a live fetus is extremely low; however, since it can lead to some sever complications in pregnancy, its correct diagnosis is really vital. Moreover, making decision about termination or continuation of pregnancy is yet controversial. This study presents a dizygotic twin pregnancy with a partial mole and a coexistent fetus which resulted a live neonate with some abnormalities
Nasrin Hashemian Nejad; Bi bi leila Hosseini
Volume 20, Issue 5 , March and April 2014, , Pages 643-647
Abstract
Introduction: Congenital arhinia is a very rare anomalia which can be observed total or partial arhinia. We assessed a case which is affected to congenital arhinia, its reasons and signs in the present study.
Case report: The patient is a 41w neonate who is affected to congenital arhinia, hypertelorism, ...
Read More
Introduction: Congenital arhinia is a very rare anomalia which can be observed total or partial arhinia. We assessed a case which is affected to congenital arhinia, its reasons and signs in the present study.
Case report: The patient is a 41w neonate who is affected to congenital arhinia, hypertelorism, cleft lip and palate. There was just a significant note in neonatal history of family which showed their first child was affected to anomalia. The neonate was transferred to a well-equip center for doing more assessments. At the present time, general condition of the neonate is good.
Conclusion: Congenital arhinia is a very rare anomaly with an unknown etiology. This anomaly may be associated with the other medline anomalies.
Bi bi leila Hosseini; MohammadHasan Rakhshani; Esmat Vafaee Fard; Mitra Aldaghi; Nasrin Hashemian Nejad
Volume 20, Issue 5 , March and April 2014, , Pages 738-746
Abstract
Backgound: Neonatal respiratory distress is a main cause of preterm neonatal mortality. Surfactant is one of its standard treatments. The current study was conducted to compare clinical effects of different kinds of surfactant in the treatment of respiratory distress of preterm neonates admitted to NICU ...
Read More
Backgound: Neonatal respiratory distress is a main cause of preterm neonatal mortality. Surfactant is one of its standard treatments. The current study was conducted to compare clinical effects of different kinds of surfactant in the treatment of respiratory distress of preterm neonates admitted to NICU of Sabzevar.
Materials and Methods: This cross-sectional study was conducted on the preterm neonates admitted to NICU of Shahid Mobini Hospital of Sabzevar University of Medical Sciences, in 2009-2010. Sample size was 115 neonates at 95% confidence interval. Inclusion criteria were neonates with respiratory distress and 26-37 weeks gestional age who had been treated with surfactant. Exclusion criteria were neonates with 5-min Apgar score less than 7, neonates with major congenital anomalies, or neonates whose mothers received steroids before giving birth. The data were gathered by questionnaire to assess clinical effects of different kinds of surfactant in the treatment of preterm neonatal respiratory distress. The questionnaire was confirmed by content validity and inter-rater reliability (r=0.9). The data were analysed in SPSS software version 20 using descriptive statistics and non-parametric tests including ANOVA and multiple comparisons, kruskalwalis and chi-square.
Results: 41 neonates were allocated in a group with birth weight less than 1500 g and 74 neonates in a group equal or grater than 1500 g. According to the statistical tests, intubation duration in neonates less than 1500 g who received Newfactan was significantly more than the two other drugs (P=0.01). Duration of CPAP in Curosurf group was more than Survanta and Newfactan groups with a significant difference. Time of starting feeding was lesser in neonates who had recieved Survanta than Newfactan. In neonates less than 1500 g, none of the variables had a significant difference after surfactant therapy.
Conclusion: This study showed that Survanta has a better efficacy than Newfactan and Curosurf. But in regard to the importance of applying this drug, and the controversy of results obtained from studies, it is recommended to perform further studies about this issue.